Obesity Medicine Course, Parts 1 and 2: Obesity and the Liver—From Metabolic Dysfunction–Associated Steatotic Liver Disease to Cardiovascular-Kidney-Liver-Metabolic Diseases (Ticketed)

Thu, Nov 5, 2026 · 1:00–4:30 PM MST Convention Center: Bluebird Ballroom 2ABC, Colorado Convention Center

About this session

This timely course provides a comprehensive overview of obesity as a multisystem disease with major implications for liver health. Using the frameworks of metabolic dysfunction–associated steatotic liver disease (MASLD) and cardiometabolic-kidney-liver-metabolic disease (CKLM), the course integrates pathophysiology, noninvasive risk stratification, and therapeutic approaches across lifestyle, pharmacologic, and procedural interventions.

Speakers

Amreen Dinani

Duke University School of Medicine

Chair
Mitchell A Mah'moud

Duke University School of Medicine

Chair
Zobair M Younossi

The Global NASH/MASH Council

Speaker
Anna Mae E Diehl

Duke University

Speaker
Alina M. Allen

Mayo Clinic Rochester

Speaker
Arun Sanyal

Virginia Commonwealth University

Speaker
Wajahat Z Mehal

Yale University

Speaker
Fernando Bril

University of Alabama at Birmingham

Speaker
Cynthia A Moylan

Duke University

Speaker
Jaime Chu

Icahn School of Medicine at Mount Sinai (ISMMS)

Speaker
Silvia Vilarinho

Yale University

Moderator

Reviews of this session

No reviews yet

Were you in the room? Reviews are open until Nov 9, 2027.

Write the first review